Abstract：OBJECTIVE: To study the clinical and pathological features of children with Duchenne muscular dystrophy (DMD), with the aim of increasing the possibility of early diagnosis. METHODS: The clinical data of 50 children who were definitely diagnosed with DMD, based on clinical manifestations and the results of skeletal muscle biopsies and monoclonal antibody immunohistochemical staining, was reviewed. RESULTS: The children showed similar clinical manifestations, including running slowly in the toddler period, muscle weakness when climbing stairs and standing up followed by squatting down and walking abnormalities a predominant increase in serum creatine kinase level increased dominantly, and myopathic lesions seen on electromyography. Hematoxylin-eosin staining showed similar pathological presentations in all 50 children, including differentsized muscle fibers with rounding, degeneration and necrosis in various degrees, and proliferation of connective tissues. There was some inflammatory cell infiltration in muscle fibers and interstitial tissues. Dystrophin expression was completely absent at the sarcolemma in all 50 children, and sarcoglycan-α,-β, -γ,-δ expression was reduced to various degrees in 33 of them. CONCLUSIONS: For children with the clinical manifestations mentioned above, skeletal muscle biopsies and monoclonal antibody immunohistochemical staining are recommended as these examinations contribute to a definite diagnosis of DMD by demonstrating dystrophin deficiency at the sarcolemma.
LI Qiu-Xiang,YANG Huan,ZHANG Ning et al. Clinical and pathological features of 50 children with Duchenne′s muscular dystrophy[J]. CJCP, 2012, 14(10): 746-750.
［3］Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion［J］. Proc Natl Acad Sci U S A, 1985, 82(14): 4778-4782.
［7］Petrof BJ. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex［J］. Am J Phys Med Rehabil, 2002, 81(11 Suppl): S162-S174.
［8］Kakulas BA. The differential diagnosis of the human dystrophinopathies and related disorders［J］. Curr Opin Neurol, 1996, 9(5): 380-388.
［9］Fairclough RJ, Bareja A, Davies KE. Progress in therapy for Duchenne muscular dystrophy ［J］. Exp Physiol, 2011, 96(11): 1101-1113.
